Researchers have developed an artificial intelligence-powered blood test capable of detecting silent liver disease before symptoms arise. This advancement could enable earlier diagnosis and intervention in patients at risk. The technology uses machine learning to analyze blood samples and identify early disease markers.
Researchers have developed an AI-powered blood test capable of detecting silent liver disease years before symptoms develop. The approach uses machine learning algorithms to analyze blood samples, offering a non-invasive method to identify at-risk patients early. Findings may improve liver disease prognosis and patient outcomes.
A new study from MIT demonstrates how high-fat diets cause liver cells to revert to a stem-cell-like state, making them more prone to cancer. By tracking gene expression in mice and human liver samples, researchers have identified drug targets that could prevent tumor development in high-risk populations.
Stay informed with curated insights delivered weekly to your inbox.